Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure
AngioDynamics is a medical instruments & supplies business based in the US. AngioDynamics shares (ANGO) are listed on the NASDAQ and all prices are listed in US Dollars. AngioDynamics employs 760 staff and has a trailing 12-month revenue of around $327.9 million.
Finder Award
SoFi Invest
Finder Award
eToro
tastytrade
| Latest market close | $12.25 |
|---|---|
| 52-week range | $11.33 - $24.87 |
| 50-day moving average | $13.02 |
| 200-day moving average | $16.89 |
| Wall St. target price | $24.00 |
| PE ratio | N/A |
| Dividend yield | $0 (0%) |
| Earnings per share (TTM) | $-0.91 |
Information on this page is for educational purposes only. Finder is not an advisor or brokerage service, and we don't recommend investors to trade specific stocks or other investments.
Finder is not a client of any featured partner. We may be paid a fee for referring prospective clients to a partner, though it is not a recommendation to invest in any one partner.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Historical closes compared with the close of $12.25 from 2023-03-20
| 1 week (2023-03-14) | -0.65% |
|---|---|
| 1 month (2023-02-21) | -4.52% |
| 3 months (2022-12-21) | -8.65% |
| 6 months (2022-09-21) | -41.08% |
| 1 year (2022-03-18) | -48.74% |
|---|---|
| 2 years (2021-03-19) | -42.54% |
| 3 years (2020-03-20) | 41.45% |
| 5 years (2018-03-21) | 16.7 |
Valuing AngioDynamics stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of AngioDynamics's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
| Revenue TTM | $327.9 million |
|---|---|
| Gross profit TTM | $164.9 million |
| Return on assets TTM | -2.47% |
| Return on equity TTM | -7.79% |
| Profit margin | -9.98% |
| Book value | $10.33 |
| Market capitalisation | $478.6 million |
TTM: trailing 12 months
We're not expecting AngioDynamics to pay a dividend over the next 12 months.
Over the last 12 months, AngioDynamics's shares have ranged in value from as little as $11.33 up to $24.87. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while AngioDynamics's is 0.6222. This would suggest that AngioDynamics's shares are less volatile than average (for this exchange).
AngioDynamics, Inc. designs, manufactures, and sells various medical, surgical, and diagnostic devices used by professional healthcare providers for the treatment of peripheral vascular disease and vascular access; and for use in oncology and surgical settings in the United States and internationally. The company provides NanoKnife ablation systems for the surgical ablation of soft tissues; solero microwave tissue ablation systems; and radiofrequency ablation products for ablating solid cancerous or benign tumors. It also offers BioSentry tract sealant systems, IsoLoc Endorectal Balloon's, alatus vaginal balloon packing systems, angiographic catheters, guidewires, percutaneous drainage catheters, and coaxial micro-introducer kits. In addition, the company provides endovascular therapies products in the areas of thrombus management, atherectomy, peripheral products (Core), and venous insufficiency. Additionally, the company offers peripherally inserted central catheters, midline catheters, implantable ports, dialysis catheters, and related accessories and supplies that are used primarily to deliver short-term drug therapies, such as chemotherapeutic agents and antibiotics, into the central venous system under the BioFlo, BioFlo Midline, BioFlo PICC, Xcela PICC, PASV, BioFlo Port, SmartPort, Vortex, LifeGuard, BioFlo DuraMax, and DuraMax names. It sells and markets its products to interventional radiologists, interventional cardiologists, vascular surgeons, urologists, interventional and surgical oncologists, and critical care nurses directly, as well as through distributor relationships.
Several ETFs have exposure to Silicon Valley Bank, but it appears minimal.
Treasury Bills are fixed-income assets with maturities of less than one year. Here’s what to know before investing.
The 16th largest US bank has collapsed, but its impact on your portfolio could be limited depending on what you own.
Steps to investing in the Vanguard (VTI) Total Stock Market ETF.
Everything we know about the Neuraxis IPO, plus information on how to buy in.
Everything we know about the TXO Energy IPO, plus information on how to buy in.
Everything we know about the Brera IPO, plus information on how to buy in.
What you need to know about investing in the leading indicator for the overall US stock market.
Buying an IPO is as simple as buying any other stock, but not every trading platform offers IPO stocks.
Steps to owning and managing NVOS, with 24-hour and historical pricing before you buy.